FGF21 Promotes Metabolic Homeostasis via White Adipose and Leptin in Mice

• Murielle M. Véniant,

  Affiliation Department of Metabolic Disorders, Amgen Inc., Thousand Oaks, California, United States of America

  ⨯
• Clarence Hale,

  Affiliation Department of Metabolic Disorders, Amgen Inc., Thousand Oaks, California, United States of America

  ⨯
• Joan Helmering,

  Affiliation Department of Metabolic Disorders, Amgen Inc., Thousand Oaks, California, United States of America

  ⨯
• Michelle M. Chen,

  Affiliation Department of Metabolic Disorders, Amgen Inc., Thousand Oaks, California, United States of America

  ⨯
• Shanaka Stanislaus,

  Affiliation Department of Metabolic Disorders, Amgen Inc., Thousand Oaks, California, United States of America

  ⨯
• Jim Busby,

  Affiliation Department of Metabolic Disorders, Amgen Inc., Thousand Oaks, California, United States of America

  ⨯
• Steven Vonderfecht,

  Affiliation Department of Pathology, Amgen Inc., Thousand Oaks, California, United States of America

  ⨯
• Jing Xu,

  Affiliation Department of Metabolic Disorders, Amgen Inc., Thousand Oaks, California, United States of America

  ⨯
• David J. Lloyd

  * E-mail: dlloyd@amgen.com

  Affiliation Department of Metabolic Disorders, Amgen Inc., Thousand Oaks, California, United States of America

  ⨯